Application of a clinical scale for predicting Aβ-positivity in a multicentre Canadian dementia cohort: A necessity in the era of amyloid targeting treatment [0.03%]
应用临床量表预测多中心加拿大痴呆症队列中的Aβ阳性：靶向淀粉样蛋白治疗时代的一项必要措施
Durjoy Lahiri,Shaaminy Kathir,Zoya Punjwani et al.
Durjoy Lahiri et al.
Background: Clinical Amyloid positivity Prediction Score (CAPS) is a clinical tool developed on a small Canadian cohort with clinical Alzheimer's Disease (AD) to help predict amyloid-beta (Aβ) positivity. The Comprehensi...
Suspected autoimmune cerebellar ataxia: Predictors of immunotherapy response and diagnosis reclassification to neurodegenerative disease [0.03%]
疑似自身免疫性小脑共济失调：免疫治疗反应的预测因素及重新诊断为神经退行性疾病的影响因素
Naoko Nakamura,Yuichiro Ii,Yoshinori Hirata et al.
Naoko Nakamura et al.
Background: Autoimmune cerebellar ataxia (ACA) is potentially treatable; however, some patients initially suspected of having ACA are later diagnosed with neurodegenerative diseases. We examined clinical features, immunot...
Comment on "impact of blood viscosity on wake-up stroke: Analysis stratified by age and stroke subtype" [0.03%]
关于“血液黏度对醒后卒中影响的分析（按年龄和卒中亚型分层）”的观点
V Magesh,G Anbahazhagan,P Mohanraj et al.
V Magesh et al.
Reply to the comment on "efficacy and safety of conventional immunosuppressant therapies in elderly patients with neuromyelitis optica spectrum disorder: A target trial emulation study" [0.03%]
关于“常规免疫抑制剂治疗视神经脊髓炎谱系病老年患者的有效性和安全性：一种目标试验模拟研究”一文的回复
Soonwook Kwon,Danbee Kang,Ju-Hong Min
Soonwook Kwon
Clinical implications of delayed insertion of implantable loop recorder: Is it still beneficial when inserted years after a stroke? [0.03%]
植入式心脏监测器延迟置入的临床意义——卒中后几年置入是否仍有益处？
Hye Bin Gwag,Nak Gyeong Ko,Mihyeon Jin
Hye Bin Gwag
Background: The efficacy of an implantable loop recorder (ILR) has been proven in detecting atrial fibrillation (AF) in embolic stroke of undetermined source (ESUS) patients. However, when patients should get ILR remains ...
Early-event pathways to 6-month death or dependency after ischemic stroke: Secondary analysis of the international stroke trial [0.03%]
缺血性脑卒中后6个月死亡或残疾的早期影响因素链：国际卒中试验的次级分析研究
Rocco Salvatore Calabrò,Andrea Calderone,Francesca Antonia Arcadi et al.
Rocco Salvatore Calabrò et al.
Background: Broad 6-month death-or-dependency outcomes after acute ischemic stroke can conceal opposing early benefit and harm pathways after antithrombotic treatment. We examined these pathways in the corrected public-us...
Association of anti-glycolipid IgG with respiratory function decline in amyotrophic lateral sclerosis [0.03%]
抗糖脂IgG与肌萎缩侧索硬化呼吸功能下降的关系
Junji Nakasako,Rena Yaguchi,Atsushi Terayama et al.
Junji Nakasako et al.
Objective: Effective treatments for amyotrophic lateral sclerosis (ALS) remain limited, underscoring the need to identify robust biomarkers associated with disease severity and prognosis. This study investigated whether i...
Polyneuropathy in p.V142I hereditary transthyretin amyloidosis: Diagnostic challenges and clinical considerations [0.03%]
p.V142I遗传性转甲状腺素蛋白淀粉样变性的多发神经病变：诊断挑战与临床考虑因素
John E Dvorak,Sami Khella,Brian Drachman et al.
John E Dvorak et al.
Reply to comment on "impact of blood viscosity on wake-up stroke: Analysis stratified by age and stroke subtype" [0.03%]
关于“血液黏度对醒后卒中影响的分析——分层年龄和卒中亚型”的评论答复
Motohiro Okumura,Takeo Sato,Yasuyuki Iguchi
Motohiro Okumura